Loading…

Human Immune Response to Streptococcal Inhibitor of Complement, a Serotype M1 Group A Streptococcus Extracellular Protein Involved in Epidemics

Streptococcal inhibitor of complement (Sic) is a highly polymorphic extracellular protein made by serotype M1 group A Streptococcus strains that contributes to bacterial persistence in the mammalian upper respiratory tract. New variants of the Sic protein arise very rapidly by positive selection in...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2000-11, Vol.182 (5), p.1425-1436
Main Authors: Hoe, Nancy P., Kordari, Parichher, Cole, Robert, Liu, Mengyao, Palzkill, Timothy, Huang, Wanzhi, McLellan, Duncan, Adams, Gerald J., Hu, Mary, Vuopio-Varkila, Jaana, Cate, Thomas R., Pichichero, Michael E., Edwards, Kathryn M., Eskola, Juhani, Low, Donald E., Musser, James M.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Streptococcal inhibitor of complement (Sic) is a highly polymorphic extracellular protein made by serotype M1 group A Streptococcus strains that contributes to bacterial persistence in the mammalian upper respiratory tract. New variants of the Sic protein arise very rapidly by positive selection in human populations during M1 epidemics. The human antibody response to Sic was analyzed. Of 636 persons living in diverse localities, 43% had anti-Sic serum antibodies, but only 16.4% had anti—M1 protein serum antibody. Anti-Sic antibody was also present in nasal wash specimens in high frequency. Linear B cell epitope mapping showed that serum antibodies recognized epitopes located in structurally variable regions of Sic and the amino terminal hypervariable region of the M1 protein. Phage display analyses confirmed that the polymorphic regions of Sic are primary targets of host antibodies. These results support the hypothesis that selection of Sic variants occurs on mucosal surfaces by a mechanism that involves acquired host antibody.
ISSN:0022-1899
1537-6613
DOI:10.1086/315882